Covered recipient · General Payments record
ADRIENNE NICOLE CHANDLER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2023
$512.44
- Reported across 13 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $250.14 | 7 |
| Education | $190.00 | 2 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $190.00 | 2 |
| Acerta Pharma LLC | $123.11 | 1 |
| ADC Therapeutics America, Inc. | $28.50 | 1 |
| Daiichi Sankyo Inc. | $23.06 | 1 |
| PharmaEssentia USA Corporation | $22.86 | 1 |
| Regeneron Healthcare Solutions, Inc. | $19.75 | 1 |
| Mirati Therapeutics, Inc. | $16.63 | 1 |
| PFIZER INC. | $16.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ADC Therapeutics America, Inc. | $28.50 | 08/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1053783947 | CMS |
| Astellas Pharma US Inc | $99.00 | 01/06/2023 | Education | Undisputed | 01/23/2026 | 1033857425 | CMS |
| Astellas Pharma US Inc | $91.00 | 01/06/2023 | Education | Undisputed | 01/23/2026 | 1033857601 | CMS |
| AstraZeneca Pharmaceuticals LP | $123.11 | 10/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014371205 | CMS |
| Daiichi Sankyo Inc. | $23.06 | 04/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006344539 | CMS |
| Mirati Therapeutics, Inc. | $16.63 | 01/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1058007271 | CMS |
| PFIZER INC. | $16.23 | 02/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1130865539 | CMS |
| PharmaEssentia USA Corporation | $22.86 | 06/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059307623 | CMS |
| Regeneron Healthcare Solutions, Inc. | $19.75 | 11/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999576831 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.